VCA
PFE icon

Verdence Capital Advisors’s Pfizer PFE Stock Holding History

Verdence Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1K Buy
+1,500
New +$39.2K ﹤0.01% 654

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Verdence Capital Advisors's PFE Position: Q2 2026 in Review

Verdence Capital Advisors reduced its Pfizer (PFE) stake by 5.9% in Q2 2026, selling an estimated $279K and leaving 168,925 shares worth $4.07M. The position accounts for 0.21% of the portfolio, ranked #107.

Verdence Capital Advisors first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $11.9M in Q3 2018. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Verdence Capital Advisors held 168,925 shares of Pfizer worth $4.07M as of Q2 2026.
  • Verdence Capital Advisors sold 10,666 Pfizer shares in Q2 2026, an estimated $279K.
  • Pfizer made up 0.21% of Verdence Capital Advisors's portfolio in Q2 2026, its #107 holding.
  • Verdence Capital Advisors first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
  • Verdence Capital Advisors's Pfizer position peaked at $11.9M in Q3 2018.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.